Lab Tests Directory
Browse our comprehensive catalog of medical tests. Book online and get tested at home or at any of our partner labs across all 7 Emirates.
Neisseria gonorrhoeae PCR
This urine test uses PCR technology to detect the genetic material of Neisseria gonorrhoeae, the bacteria that causes gonorrhea. It's a highly sensitive and accurate method for diagnosing this sexually transmitted infection.
NF1 Gene Deletion and Duplication by MLPA
This genetic test uses MLPA (Multiplex Ligation-dependent Probe Amplification) to detect deletions or duplications within the NF1 gene. Changes in this gene are associated with Neurofibromatosis Type 1, a genetic disorder affecting nerve tissue growth.
NGS CNS/Glioma Molecular Panel
This advanced test uses Next-Generation Sequencing (NGS) to analyze multiple genes associated with central nervous system (CNS) tumors, including gliomas. It identifies specific genetic alterations that can influence tumor behavior and response to treatment.
NGS COUPLE CARRIER SCREENING
This Next-Generation Sequencing (NGS) test screens couples for genetic conditions they might unknowingly carry and could pass on to their children. It helps assess the risk of offspring inheriting certain genetic disorders.
NGS COUPLE CARRIER SCREENING + DMD+SMA
This advanced Next-Generation Sequencing (NGS) test screens couples for a broad range of genetic conditions, including specific screening for Duchenne Muscular Dystrophy (DMD) and Spinal Muscular Atrophy (SMA). It provides a comprehensive risk assessment for genetic disorders that could be passed to offspring.
NPM1 Gene Mutation Qualitative
This test looks for specific changes, called mutations, in the NPM1 gene in your blood. These mutations are often found in certain types of acute myeloid leukemia (AML), a cancer of the blood and bone marrow. It helps doctors understand the specific characteristics of the disease.
NRAS Mutation Analysis
This test examines a tissue sample to identify specific mutations in the NRAS gene. These mutations can play a role in the development and progression of various cancers, including melanoma and colorectal cancer. It helps doctors choose the most effective targeted therapies.
OncoHRD ® (Tissue biopsy) A Next Generation Assistive HRD Test
This tissue biopsy test assesses Homologous Recombination Deficiency (HRD), a genetic signature in cancer cells that indicates a weakness in their DNA repair pathways. Understanding HRD status is crucial for selecting specific targeted therapies.
Oncomine Comprehensive myeloid/Leukemia Panel (DNA + RNA fusions)
This comprehensive blood test analyzes your DNA and RNA for various genetic changes, including fusions, linked to myeloid disorders and leukemia. It helps provide a detailed genetic profile to understand these complex blood conditions.
Oncomine Myeloid DNA Panel
This blood test specifically analyzes your DNA for genetic mutations frequently found in myeloid disorders, which are conditions affecting the production of certain blood cells. It provides insights into the underlying genetic causes of these conditions.
Oncomine Myeloid RNA Panel
This blood test focuses on analyzing your RNA for specific gene fusions and expressions related to myeloid disorders. These RNA changes can indicate the presence of certain blood cancers or conditions affecting blood cell production.
Osteogenesis imperfecta gene panel
The Osteogenesis Imperfecta gene panel is a genetic test that analyzes multiple genes associated with "brittle bone disease." It identifies specific mutations that can cause bones to break easily.